Professor Melanie Flint said: “With endometrial cancer rates on the rise, particularly among younger women, it is vital to understand how stress might influence the biology of these tumours. This research not only has the potential to inform future treatment strategies but also to improve quality of life by identifying the benefits of stress reduction interventions. We are immensely grateful to the Sussex Cancer Fund for supporting this important work.”
PhD student Sarah Becker said: “I’m focusing on how stress, via the glucocorticoid receptor, affects cancer growth and resistance to chemotherapy. My aim is to better understand the biological mechanisms behind these effects so we can ultimately inform treatment and care pathways for patients.”
Alongside the laboratory investigations, the research team will monitor participating patients’ stress levels through regular blood tests and quality of life assessments over the next three years. The project also contributes to the training of future clinician-researchers through a Medical Doctorate (MD) programme and findings will be presented at both national and international conferences.